A US Food and Drug Administration panel will discuss the PMA for a system that helps keep donor hearts viable during the transplant process at a 7 October meeting, the agency announced in a Federal Register notice.
The meeting of the Circulatory System Devices Panel, initially scheduled for April, was postponed due to the coronavirus pandemic. It...